BioXcel Therapeutics, Inc. (BTAI)
Total Valuation
BTAI has a market cap or net worth of $550.24 million. The enterprise value is $480.49 million.
| Market Cap | 550.24M |
| Enterprise Value | 480.49M |
Important Dates
The last earnings date was Monday, May 8, 2023, before market open.
| Earnings Date | May 8, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
BTAI has 29.16 million shares outstanding. The number of shares has increased by 2.27% in one year.
| Shares Outstanding | 29.16M |
| Shares Change (YoY) | +2.27% |
| Shares Change (QoQ) | +1.95% |
| Owned by Insiders (%) | 31.26% |
| Owned by Institutions (%) | 53.56% |
| Float | 18.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 947.06 |
| Forward PS | 9.60 |
| PB Ratio | 10.38 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 827.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.16, with a Debt / Equity ratio of 1.81.
| Current Ratio | 6.16 |
| Quick Ratio | 5.77 |
| Debt / Equity | 1.81 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -177.70% and return on invested capital (ROIC) is -239.20%.
| Return on Equity (ROE) | -177.70% |
| Return on Assets (ROA) | -85.10% |
| Return on Capital (ROIC) | -239.20% |
| Revenue Per Employee | $3,175 |
| Profits Per Employee | -$1.02M |
| Employee Count | 183 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 0.02 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +63.52% in the last 52 weeks. The beta is 1.11, so BTAI's price volatility has been higher than the market average.
| Beta (1Y) | 1.11 |
| 52-Week Price Change | +63.52% |
| 50-Day Moving Average | 21.46 |
| 200-Day Moving Average | 19.82 |
| Average Volume (30 Days) | 560,215 |
Short Selling Information
The latest short interest is 3.35 million, so 11.47% of the outstanding shares have been sold short.
| Short Interest | 3.35M |
| Short Previous Month | 3.54M |
| Short % of Shares Out | 11.47% |
| Short % of Float | 18.35% |
| Short Ratio (days to cover) | 7.50 |
Income Statement
In the last 12 months, BTAI had revenue of $581,000 and -$187.08 million in losses. Loss per share was -$6.64.
| Revenue | 581,000 |
| Gross Profit | 552,000 |
| Operating Income | -179.37M |
| Pretax Income | -187.08M |
| Net Income | -187.08M |
| EBITDA | -174.96M |
| EBIT | -175.29M |
| Loss Per Share | -$6.64 |
Balance Sheet
The company has $165.52 million in cash and $95.77 million in debt, giving a net cash position of $69.76 million or $2.39 per share.
| Cash & Cash Equivalents | 165.52M |
| Total Debt | 95.77M |
| Net Cash | 69.76M |
| Net Cash Per Share | $2.39 |
| Equity / Book Value | 53.01M |
| Book Value Per Share | 1.82 |
| Working Capital | 148.51M |
Cash Flow
In the last 12 months, operating cash flow was -$155.28 million and capital expenditures -$19,000, giving a free cash flow of -$155.30 million.
| Operating Cash Flow | -155.28M |
| Capital Expenditures | -19,000 |
| Free Cash Flow | -155.30M |
| FCF Per Share | -$5.43 |
Margins
Gross margin is 95.01%, with operating and profit margins of -30,872.63% and -32,199.48%.
| Gross Margin | 95.01% |
| Operating Margin | -30,872.63% |
| Pretax Margin | -32,199.48% |
| Profit Margin | -32,199.48% |
| EBITDA Margin | -30,113.08% |
| EBIT Margin | -30,169.88% |
| FCF Margin | -26,729.78% |
Dividends & Yields
BTAI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -34.00% |
| FCF Yield | -28.22% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.27% |
| Shareholder Yield | -2.27% |
Analyst Forecast
The average price target for BTAI is $45.83, which is 142.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $45.83 |
| Price Target Difference | 142.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 329.26% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |